These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 15521845)

  • 41. What is the best pharmacologic approach to managing moderate to severe heartburn?
    Melton ST; Cimmino A
    J Fam Pract; 2001 Oct; 50(10):839. PubMed ID: 11674880
    [No Abstract]   [Full Text] [Related]  

  • 42. Mucosal acid exposure sensitizes a subset of normal subjects to intra-oesophageal balloon distension.
    Peghini PL; Johnston BT; Leite LP; Castell DO
    Eur J Gastroenterol Hepatol; 1996 Oct; 8(10):979-83. PubMed ID: 8930562
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Psychological factors as a predictor of treatment response in patients with heartburn: a pooled analysis of clinical trials.
    Wiklund I; Carlsson R; Carlsson J; Glise H
    Scand J Gastroenterol; 2006 Mar; 41(3):288-93. PubMed ID: 16497615
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Onset of action during on-demand treatment with maalox suspension or low-dose ranitidine for heartburn.
    Faaij RA; Van Gerven JM; Jolivet-Landreau I; Masclee AA; Vendrig EM; Schoemaker RC; Jacobs LD; Cohen AF
    Aliment Pharmacol Ther; 1999 Dec; 13(12):1605-10. PubMed ID: 10594395
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Symptomatic response to blocked and unblocked pentagastrin stimulation in functional dyspepsia. Comparison of responders and non-responders to omeprazole identified in a single-subject trial model.
    Madsen LG; Bytzer P
    Dig Dis; 2008; 26(3):237-42. PubMed ID: 18463442
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of gastric pH with omeprazole magnesium 20.6 mg (Prilosec OTC) o.m. famotidine 10 mg (Pepcid AC) b.d. and famotidine 20 mg b.d. over 14 days of treatment.
    Miner PB; Allgood LD; Grender JM
    Aliment Pharmacol Ther; 2007 Jan; 25(1):103-9. PubMed ID: 17229225
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Combination oxycodone 5 mg/ibuprofen 400 mg for the treatment of pain after abdominal or pelvic surgery in women: a randomized, double-blind, placebo- and active-controlled parallel-group study.
    Singla N; Pong A; Newman K;
    Clin Ther; 2005 Jan; 27(1):45-57. PubMed ID: 15763605
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of combination treatment with ketoprofen 100 mg + acetaminophen 1000 mg on postoperative dental pain: a single-dose, 10-hour, randomized, double-blind, active- and placebo-controlled clinical trial.
    Akural EI; Järvimäki V; Länsineva A; Niinimaa A; Alahuhta S
    Clin Ther; 2009 Mar; 31(3):560-8. PubMed ID: 19393845
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of ranitidine on oesophageal motility.
    Naess F; Nygaard K; Haffner J
    Scand J Gastroenterol; 1987 Nov; 22(9):1064-6. PubMed ID: 3321394
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modern approach to the evaluation of combined effects of single-dose trials and clinical time-course studies, exemplified by combinations of pirenzepine and H2-receptor antagonists.
    Pöch G; Londong W
    Int J Clin Pharmacol Ther Toxicol; 1993 Oct; 31(10):483-8. PubMed ID: 8262686
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
    Kivitz A; Ma C; Ahdieh H; Galer BS
    Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Esophageal hypersensitivity may be a major cause of heartburn.
    Rodriguez-Stanley S; Robinson M; Earnest DL; Greenwood-Van Meerveld B; Miner PB
    Am J Gastroenterol; 1999 Mar; 94(3):628-31. PubMed ID: 10086642
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acid-related oesophageal sensitivity, not dysmotility, differentiates subgroups of patients with non-erosive reflux disease.
    Thoua NM; Khoo D; Kalantzis C; Emmanuel AV
    Aliment Pharmacol Ther; 2008 Mar; 27(5):396-403. PubMed ID: 18081729
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of ranitidine on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel.
    Small DS; Farid NA; Li YG; Ernest CS; Payne CD; Salazar DE; Winters KJ
    Curr Med Res Opin; 2008 Aug; 24(8):2251-7. PubMed ID: 18786302
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A double-blind, placebo-controlled study of the efficacy and safety of non-prescription ranitidine 75 mg in the prevention of meal-induced heartburn.
    Pappa KA; Williams BO; Payne JE; Buaron KS; Mussari KL; Ciociola AA
    Aliment Pharmacol Ther; 1999 Apr; 13(4):467-73. PubMed ID: 10215730
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Red chili induces rectal hypersensitivity in healthy humans: possible role of 5HT-3 receptors on capsaicin-sensitive visceral nociceptive pathways.
    Gonlachanvit S; Fongkam P; Wittayalertpanya S; Kullavanijaya P
    Aliment Pharmacol Ther; 2007 Aug; 26(4):617-25. PubMed ID: 17661765
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ranitidine therapy for recalcitrant warts in adults: a preliminary study.
    Karaman G; Sendur N; Sevk E
    J Eur Acad Dermatol Venereol; 2001 Sep; 15(5):495-6. PubMed ID: 11763407
    [No Abstract]   [Full Text] [Related]  

  • 58. Rapid onset of effect of sodium alginate on gastro-oesophageal reflux compared with ranitidine and omeprazole, and relationship between symptoms and reflux episodes.
    Dettmar PW; Sykes J; Little SL; Bryan J
    Int J Clin Pract; 2006 Mar; 60(3):275-83. PubMed ID: 16494641
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Esophageal visceral sensitivity to bile salts in patients with functional heartburn and in healthy control subjects.
    Siddiqui A; Rodriguez-Stanley S; Zubaidi S; Miner PB
    Dig Dis Sci; 2005 Jan; 50(1):81-5. PubMed ID: 15712642
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
    Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R
    Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.